3SBio Inc. (TRSBF)
OTCMKTS · Delayed Price · Currency is USD
4.250
-0.490 (-10.34%)
Jul 30, 2025, 10:13 AM EDT
3SBio Employees
3SBio had 5,577 employees as of December 31, 2024. The number of employees increased by 166 or 3.07% compared to the previous year.
Employees
5,577
Change (1Y)
166
Growth (1Y)
3.07%
Revenue / Employee
$223,744
Profits / Employee
$51,350
Market Cap
9.59B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,577 | 166 | 3.07% |
| Dec 31, 2023 | 5,411 | 198 | 3.80% |
| Dec 31, 2022 | 5,213 | -79 | -1.49% |
| Dec 31, 2021 | 5,292 | -236 | -4.27% |
| Dec 31, 2020 | 5,528 | 124 | 2.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
3SBio News
- 5 days ago - Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug - South China Morning Post
- 2 months ago - Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma - Benzinga
- 2 months ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 2 months ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia
- 2 months ago - Pfizer strikes deal with China's 3SBio to license cancer drug - CNBC
- 2 months ago - Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal - Benzinga